Fund V ESG

Making sustainable healthcare investments

HealthTech innovations provide several benefits to Society, according to 3 of the United Nations Sustainable Development Goals.

UN SDG 3

One primary goal : bring good health and well-being

Our selection process follows 3 key criteria

Providing Better Care

Treatment efficacy
Less toxicity
Quality of life

Lowering Costs

Saving time
Process & operations
Faster developments

Improving Access

Geographic expansion
# Patients treated
Therapeutic window

Fund objective and commitment

100% of the portfolio companies to enable a better care, at a lower cost, for all

Karista Fund V intends to demonstrate the sustainable contribution of its investments within the framework of article 9 (2) of European Sustainable Finance Disclosure Regulation (SFDR), i.e. an economic activity that contributes to a social objective within the meaning of article 2 (17) of SFDR.

Investment process

How we practically address ESG at Karista

Selecting companies compatible with our policy and objectives

Companies fitting our objective & with insignificant or manageable ESG-risk.

Ex. Social, Employee, Human Right, Anti-corruption

Company Deep-dive before closing : ESG audit + tailored target & KPIs

Tailormade Healthcare ESG objective with KPIs for targeted companies.

Ex. Manufacturing practices, Animal & Human testing, Data storage, Data privacy, software lifecycle

Operational Processing : investees’ management being incentivized

Periodical run of company-specific ESG Questionnaire, annual review by the company’s board and RemCo (= bonus of managers), annual reporting.

Ex. Product beneficiaries, Satisfaction, Healthcare facilities served

Improvement

Year over year continuous improvement to meet the impact targeted.

UN SDG 10

Beyond improving care, we support care to be accessible, and equal

UN SDG 9

Thanks to deployment of innovation, and establishment of scalable care infrastructure